Strides Pharma Science Limited has informed the Exchange regarding "Intimation pursuant to Regulation 31A of the SEBl (Listing Obligations and Disclosure Requirements) Regulations, 2015 ( SEBI Listing Regulations ) regarding Promoter Reclassification"
STAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Strides Pharma Science Limited has informed the stock exchange that it is submitting an intimation under Regulation 31A of the SEBI Listing Regulations, seeking reclassification of its promoters. This process typically means the company is requesting that certain individuals or entities currently classified as 'promoters' be reclassified as 'public' shareholders. The company has applied to the exchange and stock exchanges will now review and approve this request as per SEBI guidelines. No specific details on shareholding percentages or the names of promoters were provided in the headline.
For retail investors, this is largely a procedural disclosure and may not have an immediate impact on stock price. However, promoter reclassification can signal that promoters no longer have significant control or influence over the company, which may affect governance perception and could lead to index reclassification in some cases.